Home
Paradigm Biocapital Advisors reported a 6.1% stake in Viridian Therapeutics, Inc.\DE VRDN · 6,723,788 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.1%
- Last report
- 5.1% · filed 26/06/26
- Shares held
- 6,723,788 sh
- Class
- Common Stock, $0.01 par value per share
- Event date
- 26/06/30
- Filed
- 26/08/14
6.1% stake · +1.0pp from the last report
- Stake
- 6.1%
- Last report
- 5.1%
- Since last report
- +1.0pp
Viridian Therapeutics, Inc.\DE trades, last 26 weeks
What else happened in Viridian Therapeutics, Inc.\DE around then
Filed or reported within 30 days of the trade day · 05/31~07/30Paradigm Biocapital Advisors's other 5% stake reports
- Paradigm Biocapital Advisors
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
5.1% stake
4,457,450 sh
5.1% stake
Filed 10/01
- Paradigm Biocapital Advisors
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
5.8% stake
3,473,453 sh
5.8% stake
Filed 09/17
- Paradigm Biocapital Advisors
5% stakeAssembly Biosciences
5% stakeAssembly Biosciences
ASMB
7.8% stake
1,553,748 sh
7.8% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeLexeo Therapeutics
5% stakeLexeo Therapeutics
LXEO
5.3% stake
4,175,382 sh
5.3% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeEdgewise Therapeutics
5% stakeEdgewise Therapeutics
EWTX
9.5% stake
10,215,455 sh
9.5% stake
Filed 08/14
